Barnes Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Sell
3,931
-34
-0.9% -$1.95K 0.1% 179
2026
Q1
$240K Sell
3,965
-80
-2% -$4.66K 0.12% 164
2025
Q4
$218K Buy
+4,045
New +$195K 0.12% 169
2025
Q2
Sell
-4,823
Closed -$294K 168
2025
Q1
$294K Buy
4,823
+7
+0.1% +$408 0.19% 109
2024
Q4
$272K Buy
+4,816
New +$269K 0.18% 110

Other funds holding BMY

Barnes Wealth Management Group's BMY Position: Q2 2026 in Review

Barnes Wealth Management Group reduced its Bristol-Myers Squibb (BMY) stake by 0.86% in Q2 2026, selling an estimated $1.95K and leaving 3,931 shares worth $227K. The position accounts for 0.1% of the portfolio, ranked #179.

Barnes Wealth Management Group first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $294K in Q1 2025. 1,031 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Barnes Wealth Management Group held 3,931 shares of Bristol-Myers Squibb worth $227K as of Q2 2026.
  • Barnes Wealth Management Group sold 34 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.95K.
  • Bristol-Myers Squibb made up 0.1% of Barnes Wealth Management Group's portfolio in Q2 2026, its #179 holding.
  • Barnes Wealth Management Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • Barnes Wealth Management Group's Bristol-Myers Squibb position peaked at $294K in Q1 2025.
  • 1,031 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Barnes Wealth Management Group's 13F filing for Q2 2026, filed 24 Jul 2026.